New designs for AstraZeneca's Global R&D Centre and Corporate Headquarters in Cambridge have been unveiled.
The plans for the new development, which will be located on the Cambridge Biomedical Campus (CBC), include designs for the Global Centre, an R&D Enabling Building and an Energy Centre.
AstraZeneca is seeking Building Research Establishment Environmental Assessment Methodology (BREAAM) Excellent status for the site, which will feature labs that represent best practice in low energy design and the largest ground source heat pump in Europe.
Mene Pangalos, Executive Vice President, Innovative Medicines & Early Development at AstraZeneca said: "We are very excited to be able to reveal the plans for our new site in Cambridge today. Our aim is to create an open, welcoming and vibrant centre that will inspire our teams and partners to push the boundaries of scientific innovation."
(CD/IT)
UK
Ireland
Scotland
London











